Acrivon Therapeutics Inc. Common Stock (ACRV) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acrivon Therapeutics Inc....

    NASDAQ: ACRV · Real-Time Price · USD
    1.35
    0.05 (3.85%)
    At close: Sep 05, 2025, 11:47 AM

    Acrivon Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.01M 536K 1.09M 832K
    Gross Profit
    		 -1.01M -536K -1.09M -832K
    Operating Income
    		 -89.2M -67.24M -33.19M -16.48M
    Interest Income
    		 9.2M n/a n/a n/a
    Pretax Income
    		 -80.56M -60.39M -31.17M -16.24M
    Net Income
    		 -80.56M -60.39M -31.17M -16.24M
    Selling & General & Admin
    		 25.21M 21.21M 8.71M 2.47M
    Research & Development
    		 63.99M 45.49M 23.95M 13.72M
    Other Expenses
    		 -1.01M n/a n/a -541K
    Operating Expenses
    		 88.19M 66.7M 32.66M 15.64M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 134K n/a n/a
    Cost & Expenses
    		 89.2M 67.24M 33.19M 16.48M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 337.92M 22.08M 21.92M 20.86M
    Shares Outstanding (Diluted)
    		 337.92M 22.08M 21.92M 20.86M
    EPS (Basic)
    		 -0.24 -2.74 -1.42 -0.78
    EPS (Diluted)
    		 -0.24 -2.74 -1.42 -0.78
    EBITDA
    		 -79.55M -59.85M -30.07M -15.41M
    EBIT
    		 -80.56M -60.39M -31.17M -16.24M
    Depreciation & Amortization
    		 1.01M 536K 1.09M 832K

    Add to Watchlist